Sara Ward on X: "CAV is a recognized complication seen post-cardiac transplant and is amongst the top 3 causes of death after transplantation. Great information below regarding CAV prophylaxis for the heart
Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification | Virchows Archiv
Coronary Allograft Vasculopathy – The Achilles' Heel of Heart Transplant – The Early Career Voice
Cardiac Allograft Vasculopathy (CAV) - Weekly Research Conference with Sharon Chih, MD, PhD - YouTube
Cardiac Allograft Vasculopathy (CAV) with UCSD - CardioNerds
Established detection of CAV through its coronary sequelae. a An XRCA... | Download Scientific Diagram
Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy
Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography | PLOS ONE
Coronary Collaterals Predict Improved Survival and Allograft Function in Patients With Coronary Allograft Vasculopathy | Circulation: Heart Failure
Transplantology | Free Full-Text | Multimodality Imaging to Detect Rejection, and Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients—An Illustrative Review
Heart Transplantation Allograft Vasculopathy | Treatment & Management | Point of Care
Cardiac Allograft Vasculopathy: An Ongoing Challenge in the Care of Heart Transplant Recipients | IntechOpen
Cardiac Allograft Vasculopathy: An Ongoing Challenge in the Care of Heart Transplant Recipients (Chronic Rejection in Cardiac Transplantation) Part 1
Table 1 from Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation. | Semantic Scholar
Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era - Journal of Cardiac Failure
Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation - ScienceDirect
Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant Recipients | Circulation: Cardiovascular Interventions
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients - ScienceDirect